Treatment Outcomes of Slow Coagulation Transscleral Cyclophotocoagulation In Pseudophakic Patients with Medically Uncontrolled Glaucoma

2021 ◽  
Author(s):  
Mohamed M. Khodeiry ◽  
Huda Sheheitli ◽  
Mohamed S. Sayed ◽  
Patrice J. Persad ◽  
William Feuer ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Slow Coagulation ◽  
Transscleral Cyclophotocoagulation

Primary slow-coagulation transscleral cyclophotocoagulation laser treatment for medically recalcitrant neovascular glaucoma

2021 ◽  
pp. bjophthalmol-2021-319757
Author(s):  
Mohamed M Khodeiry ◽  
Alison J Lauter ◽  
Mohamed S Sayed ◽  
Ying Han ◽  
Richard K Lee
Keyword(s):  
Continuous Wave ◽  
Surgical Intervention ◽  
Neovascular Glaucoma ◽  
Primary Outcome Measure ◽  
Secondary Outcome ◽  
Slow Coagulation ◽  
Minimum Angle ◽  
Transscleral Cyclophotocoagulation ◽  
Cumulative Probabilities

AimsTo report treatment outcomes of slow-coagulation continuous-wave transscleral cyclophotocoagulation (TSCPC) as an initial surgical intervention in patients with neovascular glaucoma (NVG).MethodsA retrospective study including 53 patients (mean age of 69.6±16.6 years and mean follow-up of 12.7±8.9 months) with a diagnosis of NVG and no previous incisional glaucoma or cyclophotocoagulation surgeries. All patients underwent slow-coagulation continuous-wave TSCPC (1250-milliwatt power and 4-second duration).Primary outcome measure was surgical success defined as an intraocular pressure (IOP) from 6 to 21 mm Hg with a reduction ≥20% from baseline, no reoperation for glaucoma and no loss of light perception vision. Secondary outcome measures include IOP, glaucoma medications, visual acuity (VA) and complications.ResultsIOP decreased from 40.7±8.6 mm Hg preoperatively to 18.4±12.2 mm Hg postoperatively (p<0.001). The preoperative number of glaucoma medications dropped from 3.3±1.1 at baseline to 2.0±1.5 at the last postoperative visit (p<0.001). The cumulative probabilities of success at 12 and 24 months were 71.7% and 64.2 %, respectively. Mean logarithm of the minimum angle of resolution VA was relatively unchanged from 2.27±0.63 to 2.25±0.66 at the last follow-up visit (p=0.618). The most common observed complications were decrease in baseline VA (13.2%) and anterior chamber inflammation (9.4%).ConclusionsSlow-coagulation TSCPC is an effective and relatively safe initial surgical intervention in medically uncontrolled NVG.

Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma

2015 ◽  
Vol 31 (2) ◽  
pp. 393-396 ◽  
Author(s):  
Sarah Kuchar ◽  
Marlene R. Moster ◽  
Courtney B. Reamer ◽  
Michael Waisbourd
Keyword(s):  
Treatment Outcomes ◽  
Advanced Glaucoma ◽  
Transscleral Cyclophotocoagulation

Treatment Outcomes of Primary Transscleral Cyclophotocoagulation

2021 ◽  
Author(s):  
Huda Sheheitli ◽  
Patrice J. Persad ◽  
William J. Feuer ◽  
Mohamed S. Sayed ◽  
Richard K. Lee
Keyword(s):  
Treatment Outcomes ◽  
Transscleral Cyclophotocoagulation

scholarly journals Slow Coagulation Transscleral Cyclophotocoagulation for Post-Vitrectomy Patients with Silicone Oil-Induced Glaucoma

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Mohamed M. Khodeiry ◽  
XiangXiang Liu ◽  
Huda Sheheitli ◽  
Mohamed S. Sayed ◽  
Richard K. Lee
Keyword(s):  
Silicone Oil ◽  
Slow Coagulation ◽  
Transscleral Cyclophotocoagulation

Does daclizumab induction in the hepatitis C transplant recipient influence treatment outcomes

2001 ◽  
Vol 120 (5) ◽  
pp. A561-A562
Author(s):  
T HEFFRON ◽  
G SMALLWOOD ◽  
M DEVERA ◽  
L DAVIS ◽  
E MARTINEZ ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Transplant Recipient ◽  
Treatment Outcomes

Evaluating research in developmental disabilities: a conceptual framework for reviewing treatment outcomes

1999 ◽  
Vol 41 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Charlene Butler ◽  
Henry Chambers ◽  
Murray Goldstein ◽  
Susan Harris ◽  
Judy Leach ◽  
...  
Keyword(s):  
Developmental Disabilities ◽  
Conceptual Framework ◽  
Treatment Outcomes
Sign in / Sign up

Export Citation Format

Share Document